AAAAAA
Results:
1-24
|
Results: 24
Authors:
BERLIN J
STEWART JA
STORER B
TUTSCH KD
ARZOOMANIAN RZ
ALBERTI D
FEIERABEND C
SIMON K
WILDING G
Citation: J. Berlin et al., PHASE-I CLINICAL AND PHARMACOKINETIC TRIAL OF PENCLOMEDINE USING A NOVEL, 2-STAGE TRIAL DESIGN FOR PATIENTS WITH ADVANCED MALIGNANCY, Journal of clinical oncology, 16(3), 1998, pp. 1142-1149
Authors:
BOECKH M
BOWDEN RA
CHAO NJ
STORER B
SPIELBERGER R
TIERNEY DK
HAWKINS G
CUNNINGHAM T
LEVITT D
ZAIA JA
Citation: M. Boeckh et al., RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND-STUDY OF A CMV GLYCOPROTEIN H-SPECIFIC MONOCLONAL-ANTIBODY (MSL-109) FOR PREVENTION OF CMV INFECTION AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANT (HSCT), Bone marrow transplantation, 21, 1998, pp. 477-477
Authors:
YUE TL
WANG CL
ROMANIC AM
KIKLY K
KELLER P
DEWOLF WE
HART TK
THOMAS HC
STORER B
GU JL
WANG XK
FEUERSTEIN GZ
Citation: Tl. Yue et al., STAUROSPORINE-INDUCED APOPTOSIS IN CARDIOMYOCYTES - A POTENTIAL ROLE OF CASPASE-3, Journal of Molecular and Cellular Cardiology, 30(3), 1998, pp. 495-507
Authors:
OHLSTEIN EH
ARLETH AJ
STORER B
ROMANIC AM
Citation: Eh. Ohlstein et al., CARVEDILOL INHIBITS ENDOTHELIN-1 BIOSYNTHESIS IN CULTURED HUMAN CORONARY-ARTERY ENDOTHELIAL-CELLS, Journal of Molecular and Cellular Cardiology, 30(1), 1998, pp. 167-173
Authors:
ALBERTINI MR
HANK JA
SCHILLER JH
KHORSAND M
BORCHERT AA
GAN J
BECHHOFER R
STORER B
REISFELD RA
SONDEL PM
Citation: Mr. Albertini et al., PHASE IB TRIAL OF CHIMERIC ANTIDISIALOGANGLIOSIDE ANTIBODY PLUS INTERLEUKIN-2 FOR MELANOMA PATIENTS, Clinical cancer research, 3(8), 1997, pp. 1277-1288
Authors:
TANNEHILL SP
MEHTA MP
LARSON M
STORER B
PELLET J
KINSELLA TJ
SCHILLER JH
Citation: Sp. Tannehill et al., EFFECT OF AMIFOSTINE ON TOXICITIES ASSOCIATED WITH SEQUENTIAL CHEMOTHERAPY AND RADIATION-THERAPY FOR UNRESECTABLE NON-SMALL-CELL LUNG-CANCER - RESULTS OF A PHASE-II TRIAL, Journal of clinical oncology, 15(8), 1997, pp. 2850-2857
Authors:
DEMIRER T
BUCKNER CD
STORER B
LILLEBY K
ROWLEY S
CLIFT R
APPELBAUM FR
STORB R
BENSINGER WI
Citation: T. Demirer et al., EFFECT OF DIFFERENT CHEMOTHERAPY REGIMENS ON PERIPHERAL-BLOOD STEM-CELL COLLECTIONS IN PATIENTS WITH BREAST-CANCER RECEIVING GRANULOCYTE-COLONY-STIMULATING FACTOR, Journal of clinical oncology, 15(2), 1997, pp. 684-690
Authors:
CLEARY JF
ARZOOMANIAN R
ALBERTI D
FEIERABEND C
STORER B
WITT P
CARBONE P
WILDING G
Citation: Jf. Cleary et al., A PHASE-I STUDY OF 5-FLUOROURACIL, LEUCOVORIN AND LEVAMISOLE, Cancer chemotherapy and pharmacology, 39(4), 1997, pp. 300-306
Authors:
WITTENKELLER JL
STORER B
BITTNER G
SCHILLER JH
Citation: Jl. Wittenkeller et al., COMPARISON OF SPONTANEOUS AND INDUCED MUTATION-RATES IN AN IMMORTALIZED HUMAN BRONCHIAL EPITHELIAL-CELL LINE AND ITS TUMORIGENIC DERIVATIVE, Oncology, 54(4), 1997, pp. 335-341
Authors:
HOLMBERG LA
STORER B
SANDMAIER BM
BUCKNER CD
BENSINGER WJ
ROWLEY SD
Citation: La. Holmberg et al., AUTOLOGOUS TRANSPLANT USING INTERLEUKIN-2 (IL2) TREATED PERIPHERAL-BLOOD STEM-CELLS (PBSC) IN PATIENTS WITH ADVANCED MALIGNANCIES, Blood, 90(10), 1997, pp. 494-494
Authors:
SLATTERY JT
CLIFT RA
BUCKNER CD
RADICH J
STORER B
BENSINGER WI
SOLL E
ANASETTI C
BOWDEN R
BRYANT E
CHAUNCEY T
DEEG HJ
DONEY KC
FLOWERS M
GOOLEY T
HANSEN JA
MARTIN PJ
MCDONALD GB
NASH R
PETERSDORF EW
SANDERS JE
SCHOCH G
STEWART P
STORB R
SULLIVAN KM
THOMAS ED
WITHERSPOON RP
APPELBAUM FR
Citation: Jt. Slattery et al., MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - THE INFLUENCE OF PLASMA BUSULFAN LEVELS ON THE OUTCOME OF TRANSPLANTATION, Blood, 89(8), 1997, pp. 3055-3060
Authors:
SIERRA J
STORER B
HANSEN JA
BJERKE JW
MARTIN PJ
PETERSDORF EW
APPELBAUM FR
BRYANT E
CHAUNCEY TR
SALE G
SANDERS JE
STORB R
SULLIVAN KM
ANASETTI C
Citation: J. Sierra et al., TRANSPLANTATION OF MARROW-CELLS FROM UNRELATED DONORS FOR TREATMENT OF HIGH-RISK ACUTE-LEUKEMIA - THE EFFECT OF LEUKEMIC BURDEN, DONOR HLA-MATCHING, AND MARROW CELL DOSE, Blood, 89(11), 1997, pp. 4226-4235
Authors:
SCHILLER JH
HANK JA
KHORSAND M
STORER B
BORCHERT A
HUSEBYMOORE K
BURNS D
WESLY O
ALBERTINI MR
WILDING G
SONDEL PM
Citation: Jh. Schiller et al., CLINICAL AND IMMUNOLOGICAL EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR COADMINISTERED WITH INTERLEUKIN-2 - A PHASE IB STUDY, Clinical cancer research, 2(2), 1996, pp. 319-330
Authors:
ALBERTINI MR
GAN J
JAEGER P
HANK JA
STORER B
SCHELL K
RIVEST T
SURFUS J
REISFELD RA
SCHILLER JH
SONDEL PM
Citation: Mr. Albertini et al., SYSTEMIC INTERLEUKIN-2 MODULATES THE ANTIIDIOTYPIC RESPONSE TO CHIMERIC ANTI-GD2 ANTIBODY IN PATIENTS WITH MELANOMA, Journal of immunotherapy with emphasis on tumor immunology, 19(4), 1996, pp. 278-295
Authors:
WIEDEMANN GJ
ROBINS HI
GUTSCHE S
MENTZEL M
DEEKEN M
KATSCHINSKI DM
ELEFTHERIADIS S
CRAHE R
WEISS C
STORER B
WAGNER T
Citation: Gj. Wiedemann et al., IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE (ICE) COMBINED WITH 41.8-DEGREES-C WHOLE-BODY HYPERTHERMIA IN PATIENTS WITH REFRACTORY SARCOMA, European journal of cancer, 32A(5), 1996, pp. 888-892
Authors:
ARLETH AJ
STORER B
ROMANIC AM
OHLSTEIN EH
Citation: Aj. Arleth et al., CARVEDILOL INHIBITS ENDOTHELIN-1 BIOSYNTHESIS IN CULTURED HUMAN CORONARY-ARTERY ENDOTHELIAL-CELLS, Circulation, 94(8), 1996, pp. 2335-2335
Authors:
HANK JA
ALBERTINI M
WESLY OH
SCHILLER JH
BORCHERT A
MOORE K
BECHHOFER R
STORER B
GAN J
GAMBACORTI C
SOSMAN J
SONDEL PM
Citation: Ja. Hank et al., CLINICAL AND IMMUNOLOGICAL EFFECTS OF TREATMENT WITH MURINE ANTI-CD3 MONOCLONAL-ANTIBODY ALONG WITH INTERLEUKIN-2 IN PATIENTS WITH CANCER, Clinical cancer research, 1(5), 1995, pp. 481-491
Authors:
SCHILLER JH
LARSON ML
LARSON MH
PHARO L
MEHTA M
STORER B
Citation: Jh. Schiller et al., AMIFOSTINE (A), CISPLATIN (C), VINBLASTINE (V) - A HIGHLY-ACTIVE REGIMEN FOR NON-SMALL-CELL LUNG-CANCER (NSCLC), European journal of cancer, 31A, 1995, pp. 1106-1106
Authors:
SIERRA J
STORER B
HANSEN J
MARTIN P
PETERSDORF E
APPLEBAUM E
BUCKNER D
SALE G
SANDERS J
ANASETTI C
Citation: J. Sierra et al., UNRELATED DONOR MARROW TRANSPLANTS (URD-BMT) FOR ACUTE-LEUKEMIA (AL), Blood, 86(10), 1995, pp. 1146-1146
Authors:
TRENTHAMDIETZ A
NEWCOMB P
STORER B
LONGNECKER M
MITTENDORF R
Citation: A. Trenthamdietz et al., MULTIPLE BIRTHS AND RISK OF BREAST-CANCER, American journal of epidemiology, 141(11), 1995, pp. 16-16
Authors:
SCHILLER JH
STORER B
TUTSCH K
ARZOOMANIAN R
ALBERTI D
FEIERABEND C
SPRIGGS D
Citation: Jh. Schiller et al., PHASE-I TRIAL OF 3-HOUR INFUSION OF PACLITAXEL WITH OR WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH ADVANCED CANCER, Journal of clinical oncology, 12(2), 1994, pp. 241-248
Authors:
SCHILLER JH
STORER B
TUTSCH K
ARZOOMANIAN R
ALBERTI D
FEIERABEND C
SPRIGGS D
Citation: Jh. Schiller et al., A PHASE-I TRIAL OF 3-HOUR INFUSIONS OF PACLITAXEL (TAXOL) WITH OR WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR, Seminars in oncology, 21(5), 1994, pp. 9-14
Authors:
NAMBI P
PULLEN M
SLIVJAK MJ
OHLSTEIN EH
STORER B
SMITH EF
Citation: P. Nambi et al., ENDOTOXIN-MEDIATED CHANGES IN PLASMA ENDOTHELIN CONCENTRATIONS, RENALENDOTHELIN RECEPTOR AND RENAL-FUNCTION, Pharmacology, 48(3), 1994, pp. 147-156
Authors:
SCHILLER JH
STORER B
ARZOOMANIAN R
TUTSCH K
ALBERTI D
SPRIGGS D
Citation: Jh. Schiller et al., PHASE-I TRIAL OF MITOXANTRONE AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN PATIENTS WITH ADVANCED SOLID MALIGNANCIES, Investigational new drugs, 11(4), 1993, pp. 291-300
Risultati:
1-24
|